Search

Your search keyword '"VanLent A"' showing total 15 results
Start Over Author "VanLent A"
15 results on '"VanLent A"'

2. The Image of Higher Education in American Indian Popular Literature.

Author

vanLent, Peter

Abstract

In their attempts to lead a dual-life experience, characters in popular literature written by and/or about Native American Indians occasionally enroll in institutions of higher education; like many of their real-life counterparts very few of these student characters find the experience to be a positive undertaking. This narrative pattern reflects a "tragic reality" in American higher education today. The paper deals with four novels which target specific problems encountered by Native American students in college, i.e.: "Wolfsong" (Louis Owen); "Turtle Belly" (Joel Monture); "First Eagle" (Tony Hillerman); and "Agoak" (Yves Theriault). Parallels can be drawn between reality and the negative image of higher education in American Indian popular literature, since the primary reasons for higher education's failure with Native Americans are outlined in the novels discussed: social maladjustment, disinterested faculty, irrelevant curriculum, lack of a support network, alienation from personal heritage, racism, etc. The paper suggests some ways to ameliorate the situation, such as establishing residence halls where a support community can be formed, hiring Native American counselors to facilitate positive peer communication, and organizing tutoring programs. Contains 6 references. (NKA)

Published
1999

5. US immigration order strikes against biotech

Author

Robert Langer, John M. Maraganore, David P. Schenkein, Neil Warma, Chris Adams, Chip Clark, Mark Levin, William Rastetter, Bruce A Leicher, Nancy A Thornberry, Robert I Blum, Jonathan G Rosin, Kleanthis G Xanthopoulos, Timothy D. Harris, Jeff L Cleland, Robert Forrester, Nancy Simonian, Peter Barrett, Stephen Bloch, William J Rieflin, Brian M Gallagher, Lewis Rusty Williams, Doug Doerfler, Richard Ulevitch, David R. Liu, Andrew Levin, P. Grint, Nick J Simon, Pablo J Cagnoni, Daphne Zohar, Kush M Parmar, Guy Macdonald, Corey M McCann, Stelios Papadopoulos, Michael D Clayman, Diego Miralles, Paula Cobb, John Diekman, Jeremy M Levin, Amir Nashat, Samuel G Waksal, Rachel King, Sandford Sandy Zweifach, Gail J Maderis, Ankit Mahadevia, Heather Franklin, Cary G Pfeffer, Steven K Brauer, Akshay Vaishnaw, Clay B. Siegall, Howard Furst, Jonathan S Leff, William J Rutter, Dennis J. Purcell, Mary T Szela, J C Gutierrez-Ramos, Sean A McCarthy, Elizabeth Lr Donley, Yaron Werber, Doug E Williams, Christoph Westphal, Paul Sekhri, W Eddie Martucci, Jeb Keiper, John E Osborn, Simba Gill, Bassil Dahiyat, Steven H Holtzman, Annalisa Jenkins, Saurabh Saha, Matthew J. During, Camille Samuels, Mara G Aspinall, Chad Robins, Jason P Rhodes, Herve Hoppenot, Jeff Kaplan, Michael A Narachi, Amit Rakhit, Julia C Owens, Steve M Paul, Martin Varsavsky, Mark G. Currie, Rajeev Shah, Rob Perez, H. Stewart Parker, Jeff Stein, Leonard Patrick Gage, Perry Karsen, Joel F Martin, Bob More, Matthew Perry, James G McArthur, Gregory J Flesher, Martin Tolar, Andrew Schwab, James A Geraghty, Eric L Dobmeier, Brook Byers, Vanessa King, Mason W. Freeman, Larry Miller, Marco Taglietti, Jeff Albers, Neil A Exter, Michael W Bonney, Ron Cohen, Nick Leschly, Bruce L Booth, William J Newell, Peter Kolchinsky, Ryan J Watts, Paul Laikind, Andrew G. Myers, Cedric Francois, Stephen T Isaacs, Scott Koenig, Michel Vounatsos, Tuan Ha-Ngoc, Nicholas Galakatos, George P Vlasuk, Isaac Ciechanover, Jeff Kindler, Brian M. Cali, Matthew R Patterson, Kenneth I Moch, Tom Graney, Martin Babler, Jonathan J Fleming, Mark A Goldsmith, Daniel M Bradbury, John Mendlein, Mike Powell, Nessan Bermingham, Eric Elenko, H. Robert Horvitz, Yujiro Steve Hata, Mark Pruzanski, Faheem Hasnain, Henri A. Termeer, Maxine Gowen, Scott M Rocklage, Anne VanLent, Thomas Shenk, Leslie Henshaw, Jeff Jonker, Nina Kjellson, Deborah Dunsire, Zoe Barry, Ron C Renaud, Alex Martin, Uri Lopatin, George Scangos, Jean Kim, Kartik Ramamoorthi, Michael Rosenblatt, Nagesh K Mahanthappa, Harvey F. Lodish, Paul B Bolno, Wendell Wierenga, Atul Pande, Barry Greene, Alan Levy, Adrian Ad Rawcliffe, Wende S Hutton, C Geoffrey McDonough, Vicki L. Sato, Jean-Francois Formela, David V. Goeddel, Bill Haney, Rich Heyman, James E Audia, Ron Cooper, Nina Tandon, Brett Ahrens, Julian Adams, Peter Hecht, John J Lee, Stuart L. Schreiber, Laurence E Reid, Bernat Olle, Paul Hastings, John A. Scarlett, Michael Su, David Grayzel, Ted W Love, Arnold J. Levine, Gerhard Koenig, Thomas E Hughes, Jens W Eckstein, Wendy Nelson, and Vikas Goyal

Subjects
0301 basic medicine, business.industry, media_common.quotation_subject, Population Dynamics, Immigration, Biomedical Engineering, Public Policy, Bioengineering, International trade, Emigration and Immigration, Applied Microbiology and Biotechnology, 03 medical and health sciences, 030104 developmental biology, Order (business), Political science, Humans, Molecular Medicine, business, Biotechnology, media_common
Published
2017

6. US immigration order strikes against biotech

Author

Levin, Jeremy M, primary, Holtzman, Steven H, additional, Maraganore, John, additional, Hastings, Paul J, additional, Cohen, Ron, additional, Dahiyat, Bassil, additional, Adams, Julian, additional, Adams, Chris, additional, Ahrens, Brett, additional, Albers, Jeff, additional, Aspinall, Mara G, additional, Audia, James E, additional, Babler, Martin, additional, Barrett, Peter, additional, Barry, Zoe, additional, Bermingham, Nessan, additional, Bloch, Stephen, additional, Blum, Robert I, additional, Bolno, Paul B, additional, Bonney, Michael W, additional, Booth, Bruce, additional, Bradbury, Daniel M, additional, Brauer, Steven K, additional, Byers, Brook, additional, Cagnoni, Pablo J, additional, Cali, Brian M, additional, Ciechanover, Isaac, additional, Clark, Chip, additional, Clayman, Michael D, additional, Cleland, Jeff L, additional, Cobb, Paula, additional, Cooper, Ron, additional, Currie, Mark G, additional, Diekman, John, additional, Dobmeier, Eric L, additional, Doerfler, Doug, additional, Donley, Elizabeth LR, additional, Dunsire, Deborah, additional, During, Matthew, additional, Eckstein, Jens W, additional, Elenko, Eric, additional, Exter, Neil A, additional, Fleming, Jonathan J, additional, Flesher, Gregory J, additional, Formela, Jean-Francois, additional, Forrester, Robert, additional, Francois, Cedric, additional, Franklin, Heather, additional, Freeman, Mason W, additional, Furst, Howard, additional, Gage, Leonard Patrick, additional, Galakatos, Nicholas, additional, Gallagher, Brian M, additional, Geraghty, James A, additional, Gill, Simba, additional, Goeddel, David V, additional, Goldsmith, Mark A, additional, Gowen, Maxine, additional, Goyal, Vikas, additional, Graney, Tom, additional, Grayzel, David, additional, Greene, Barry, additional, Grint, Paul, additional, Gutierrez-Ramos, J C, additional, Haney, Bill, additional, Ha-Ngoc, Tuan, additional, Harris, Tim, additional, Hasnain, Faheem, additional, Hata, Yujiro Steve, additional, Hecht, Peter, additional, Henshaw, Leslie, additional, Heyman, Rich, additional, Hoppenot, Herve, additional, Horvitz, H Robert, additional, Hughes, Thomas E, additional, Hutton, Wende S, additional, Isaacs, Stephen T, additional, Jenkins, Annalisa, additional, Jonker, Jeff, additional, Kaplan, Jeff, additional, Karsen, Perry, additional, Keiper, Jeb, additional, Kim, Jean, additional, Kindler, Jeff, additional, King, Rachel, additional, King, Vanessa, additional, Kjellson, Nina, additional, Koenig, Scott, additional, Koenig, Gerhard, additional, Kolchinsky, Peter, additional, Laikind, Paul, additional, Langer, Robert, additional, Lee, John J, additional, Leff, Jonathan S, additional, Leicher, Bruce A, additional, Leschly, Nick, additional, Levin, Andrew, additional, Levin, Mark, additional, Levine, Arnold J, additional, Levy, Alan, additional, Liu, David R, additional, Lodish, Harvey F, additional, Lopatin, Uri, additional, Love, Ted W, additional, Macdonald, Guy, additional, Maderis, Gail J, additional, Mahadevia, Ankit, additional, Mahanthappa, Nagesh K, additional, Martin, Joel F, additional, Martin, Alex, additional, Martucci, W Eddie, additional, McArthur, James G, additional, McCann, Corey M, additional, McCarthy, Sean A, additional, McDonough, C Geoffrey, additional, Mendlein, John, additional, Miller, Larry, additional, Miralles, Diego, additional, Moch, Kenneth I, additional, More, Bob, additional, Myers, Andrew G, additional, Narachi, Michael A, additional, Nashat, Amir, additional, Nelson, Wendy, additional, Newell, William J, additional, Olle, Bernat, additional, Osborn, John E, additional, Owens, Julia C, additional, Pande, Atul, additional, Papadopoulos, Stelios, additional, Parker, H Stewart, additional, Parmar, Kush M, additional, Patterson, Matthew R, additional, Paul, Steve M, additional, Perez, Rob, additional, Perry, Matthew, additional, Pfeffer, Cary G, additional, Powell, Mike, additional, Pruzanski, Mark, additional, Purcell, Dennis J, additional, Rakhit, Amit, additional, Ramamoorthi, Kartik, additional, Rastetter, William, additional, Rawcliffe, Adrian, additional, Reid, Laurence E, additional, Renaud, Ron C, additional, Rhodes, Jason P, additional, Rieflin, William J, additional, Robins, Chad, additional, Rocklage, Scott M, additional, Rosenblatt, Michael, additional, Rosin, Jonathan G, additional, Rutter, William J, additional, Saha, Saurabh, additional, Samuels, Camille, additional, Sato, Vicki L, additional, Scangos, George, additional, Scarlett, John A, additional, Schenkein, David, additional, Schreiber, Stuart L, additional, Schwab, Andrew, additional, Sekhri, Paul, additional, Shah, Rajeev, additional, Shenk, Thomas, additional, Siegall, Clay B, additional, Simon, Nick J, additional, Simonian, Nancy, additional, Stein, Jeff, additional, Su, Michael, additional, Szela, Mary T, additional, Taglietti, Marco, additional, Tandon, Nina, additional, Termeer, Henri, additional, Thornberry, Nancy A, additional, Tolar, Martin, additional, Ulevitch, Richard, additional, Vaishnaw, Akshay K, additional, VanLent, Anne, additional, Varsavsky, Martin, additional, Vlasuk, George P, additional, Vounatsos, Michel, additional, Waksal, Samuel G, additional, Warma, Neil, additional, Watts, Ryan J, additional, Werber, Yaron, additional, Westphal, Christoph, additional, Wierenga, Wendell, additional, Williams, Doug E, additional, Williams, Lewis, additional, Xanthopoulos, Kleanthis G, additional, Zohar, Daphne, additional, and Zweifach, Sandford, additional

Published
2017
Full Text
View/download PDF

7. Human-Level AI's Killer Application: Interactive Computer Games

Author

Laird, John and VanLent, Michael

Subjects
ComputingMethodologies_PATTERNRECOGNITION, ComputingMilieux_PERSONALCOMPUTING, GeneralLiterature_MISCELLANEOUS
Abstract

Although one of the fundamental goals of AI is to understand and develop intelligent systems that have all the capabilities of humans, there is little active research directly pursuing this goal. We propose that AI for interactive computer games is an emerging application area in which this goal of human-level AI can successfully be pursued. Interactive computer games have increasingly complex and realistic worlds and increasingly complex and intelligent computer-controlled characters. In this article, we further motivate our proposal of using interactive computer games for AI research, review previous research on AI and games, and present the different game genres and the roles that human-level AI could play within these genres. We then describe the research issues and AI techniques that are relevant to each of these roles. Our conclusion is that interactive computer games provide a rich environment for incremental research on human-level AI.

Published
2001

9. Analysis of Spatial Variability Using a Numerical Spectral Approach

Author

Thomas VanLent and Peter K. Kitanidis

Subjects
Stochastic partial differential equation, Partial differential equation, Computer science, Numerical analysis, Finite difference method, Finite difference, Applied mathematics, Covariance, Spectral method, Finite element method
Abstract

Numerical spectral methods are alternatives to finite elements and finite differences for solving partial differential equations. In this paper, we discuss how characteristics particular to spectral methods make them ideally suited for some problems of relating covariances using the physically based governing equations. We examine the approximations required for the numerical method, and compare numerical spectral methods to finite element and finite difference methods. Finally, we demonstrate how the numerical spectral method can be applied to any valid log-permeability covariance by providing an example using a piece-wise linear covariance. The numerical spectral methods are computationally efficient and flexible. We conclude that numerical spectral methods offer an excellent practical way of using stochastic partial differential equations to derive the statistical characteristics of variables of interest in geohydrologic applications.

Published
1991

10. LONG-TERM SURVIVAL IN OVARIAN-CANCER - MATURE DATA FROM THE NETHERLANDS JOINT STUDY-GROUP FOR OVARIAN-CANCER

Author

NEIJT, JP, HUININK, WWT, VANDERBURG, MEL, VANOOSTEROM, AT, WILLEMSE, PHB, VERMORKEN, JB, VANLINDERT, ACM, HEINTZ, APM, AARTSEN, E, VANLENT, M, TRIMBOS, JB, DEMEIJER, AJ, and Faculteit Medische Wetenschappen/UMCG

Subjects
CARCINOMA, CHAP-5
Abstract

In two studies initiated in 1979 and 1981, 377 patients were treated for advanced epithelial ovarian cancer. In the first study patients were randomly assigned to receive Hexa-CAF (hexamethylmelamine, cyclophosphamide, methotrexate, 5-fluorouracil) or CHAP-5 (cyclophosphamide, hexamethylmelamine, doxorubicin, cisplatin for 5 days) and in the second study to receive CHAP-5 or CP (cyclophosphamide, cisplatin on 1 day). Patients who did not respond to Hexa-CAF were offered subsequent treatment that included cisplatin. Median follow-up of patients in the first study was 9.5 years and in the second study 7.7 years. At 10 years 9% of the patients initially treated with Hexa-CAF and 21% of patients assigned to CHAP-5 were alive. Among the 10-year survivors treated with Hexa-CAF, 50% had experienced progressive disease but were alive as a result of retreatment with a cisplatin regimen. The survival curves of both studies revealed that approximately 60% of the patients who reached a complete remission were alive at 5 years and 40% at 10 years. Patients with microscopic disease at second-look had a less favourable outlook: 35% survived 5 years. Not recognised at first publication of both studies was the influence of tumour grade on survival. Before 5 years of follow-up, the good prognosis of grade 1 tumours (well differentiated) could not be detected. About 50% of patients with grade 1 tumours were alive at 5 and 30% at 10 years while these survival rates were halved for the other grades. Combination chemotherapy with cisplatin can enhance survival by more than 10% at 5 and 10 years compared with the best treatment of the precisplatin era: Hexa-CAF.

Published
1991

15. BARRIER BREAKS THE MOLD.

Author

VanLent, Anne

Subjects
JOINT ventures, MERCHANDISE licensing
Abstract

Focuses on the capital venture of Barrier Therapeutics in New Jersey. Details on the deal to license compounds from pharmaceutical giant Johnson & Johnson in New Brunswick; Acquisition of licensing rights; Use of soy extract for cosmetic and therapeutic benefits.

Published
2002

Catalog

Books, media, physical & digital resources
See catalog results